Plasma Cells in Health and Disease
Plasma Cells in Health and Disease
批准号:
10621320
负责人:
Ignacio E. Sanz
金额:
$269.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
未结题
起止时间:
2016-06-25 至 2027-04-30
关键词:
AcuteAllergic ReactionAnimalsAntibodiesAntigensAreaAutoimmune DiseasesAutoimmune ResponsesB-LymphocytesBioinformaticsBiological Response Modifier TherapyBone MarrowCOVID-19 pandemicCRISPR/Cas technologyCell AgingCell CompartmentationCell Differentiation processCell MaturationCell SurvivalCell physiologyCellsChromatinComplementary DNAComputer AnalysisDNA MethylationData SetDevelopmentDiseaseEZH2 geneEndowmentEnsureEpigenetic ProcessFoundationsGenerationsGenetic TranscriptionGenome engineeringGoalsGraft RejectionHealthHemeHeterogeneityHumanHypersensitivityImmune systemImmunoglobulin AImmunoglobulin GImmunoglobulin MImmunoglobulin-Secreting CellsInfectionInformation DisseminationInstitutionInvestigationIronLaboratory PersonnelLibrariesLongevityMediatingMemoryMemory B-LymphocyteMetabolicMetabolismMolecularNaturePathogenicityPathway interactionsPlasma CellsPlasmablastPopulationPreparationProcessProductionRegulationResearch PersonnelRoleSIRT1 geneSafetySerologySystemic Lupus ErythematosusTranscriptional RegulationVaccinationWorkarmautoreactivitybasedata sharingdesigneffective therapyepigenetic regulationepigenomicshistone modificationhuman tissueimmune functionimmunogenicimprovedmethylation patternoverexpressionprogramsresponsetranscriptomevaccine response
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Antibody secreting cells (ASC) are responsible for both protective and pathogenic responses
through the function of populations endowed with different function and longevity. Hence, major
unmet need in human health and disease is a deep understanding of the processes that underlie
ASC generation from different B cell precursors through separate differentiation pathways; the
metabolic, transcriptional and epigenetic programs that underpin these processes, thereby
promoting the generation of diverse ASC populations of different longevity and function; and how
these processes may be subverted in SLE leading to expansion of pathogenic autoreactive
plasma cells. Proper ASC function and dysregulation respectively provide protection in
vaccination and infection and mediate multiple diseases including SLE and other autoimmune
conditions, allergic reactions and transplant rejection. Thus, understanding the processes that
regulate differentiation and survival of protective ASC while avoiding the accumulation of
pathogenic ones is essential for our ability to improve vaccination and treat multiple antibody-
mediated diseases.
Over the previous cycle, despite the severe disruption caused by the COVID-19 pandemic for
over a year, our work has contributed major progress in these areas that provides the foundation
for this renewal application. Combined, our work will address the following concepts: Theme 1 -
ASC heterogeneity in human healthy and autoimmune responses; Theme 2 - Molecular and
epigenetic regulation of PC development and survival; Theme 3 - Metabolic regulation of ASC
differentiation, function and survival; Theme 4: Microenvironment regulation of ASC formation,
survival and function. These goals will be accomplished by highly interactive investigators through
the following Projects and cores:
Project 1. Epigenetic and metabolic mechanisms governing commitment to the long-lived
plasma cell pool (Lund, PI).
Project 2. Epigenetic programming of plasma cell heterogeneity and metabolism. (Boss, PI)
Project 3. Role of Cellular Senescence in long-lived plasma cell generation. (Lee, PI)
Project 4. Heterogeneity. Regulation and Function of Antibody-Secreting Cells in SLE (Sanz, PI)
Core A. Administrative Core (Sanz, PI)
Core B. Epigenomics, Bioinformatics, and Genome Engineering (Scharer, PI)
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Autoreactive monoclonal antibodies from patients with primary biliary cholangitis recognize environmental xenobiotics.
来自原发性胆管炎患者的自身反应性单克隆抗体识别环境异种生物。
DOI:
10.1002/hep.29245
发表时间:
2017-09
期刊:
Hepatology (Baltimore, Md.)
影响因子:
--
作者:
[Tanaka T, Zhang W, Sun Y, Shuai Z, Chida AS, Kenny TP, Yang GX, Sanz I, Ansari A, Bowlus CL, Ippolito GC, Coppel RL, Okazaki K, He XS, Leung PSC, Gershwin ME]
通讯作者:
Gershwin ME
DOI:
10.1111/imr.12660
发表时间:
2018-07
期刊:
Immunological reviews
影响因子:
8.7
作者:
[Tipton CM, Hom JR, Fucile CF, Rosenberg AF, Sanz I]
通讯作者:
Sanz I
DOI:
10.1038/nrrheum.2016.191
发表时间:
2016-11-22
期刊:
Nature reviews. Rheumatology
影响因子:
--
作者:
[Sanz I]
通讯作者:
Sanz I
DOI:
10.1002/art.40109
发表时间:
2017-08
期刊:
Arthritis & rheumatology (Hoboken, N.J.)
影响因子:
--
作者:
[Sanz I]
通讯作者:
Sanz I
DOI:
10.1093/cid/ciab448
发表时间:
2021-12-06
期刊:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
影响因子:
--
作者:
[Vanijcharoenkarn K, Lee FE, Martin L, Shih J, Sexton ME, Kuruvilla ME]
通讯作者:
Kuruvilla ME
Molecular Regulation of B cells and T cells in Human SLE
-
批准号:10493525
-
项目类别:
-
资助金额:$8.88万
-
财政年份:2021
-
负责人:Ignacio E. Sanz
-
依托单位:
ACE Funds Management Core
-
批准号:10439991
-
项目类别:
-
资助金额:$17.17万
-
财政年份:2021
-
负责人:Ignacio E. Sanz
-
依托单位:
ACE Covid 19 Admin Supplement: Molecular Regulation of B cells and T cells in Human SLE
-
批准号:10456447
-
项目类别:
-
资助金额:$2679.42万
-
财政年份:2021
-
负责人:Ignacio E. Sanz
-
依托单位:
Molecular Regulation of B cells and T cells in Human SLE
-
批准号:10439989
-
项目类别:
-
资助金额:$17.17万
-
财政年份:2021
-
负责人:Ignacio E. Sanz
-
依托单位:
Administrative Supplement Covid19: Molecular Regulation of B cells and T cells in Human SLE
-
批准号:10164943
-
项目类别:
-
资助金额:$52.56万
-
财政年份:2020
-
负责人:Ignacio E. Sanz
-
依托单位:
Molecular Regulation of B cells and T cells in Human SLE
-
批准号:10265747
-
项目类别:
-
资助金额:$37.47万
-
财政年份:2020
-
负责人:Ignacio E. Sanz
-
依托单位:
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity
-
批准号:10680628
-
项目类别:
-
资助金额:$15.96万
-
财政年份:2020
-
负责人:Ignacio E. Sanz
-
依托单位:
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity
-
批准号:10680631
-
项目类别:
-
资助金额:$35.92万
-
财政年份:2020
-
负责人:Ignacio E. Sanz
-
依托单位:
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity
-
批准号:10222317
-
项目类别:
-
资助金额:$31.82万
-
财政年份:2020
-
负责人:Ignacio E. Sanz
-
依托单位:
Regulation of Pathogenic Plasma Cells in Human SLE
-
批准号:10187509
-
项目类别:
-
资助金额:$174.78万
-
财政年份:2020
-
负责人:Ignacio E. Sanz
-
依托单位:
Principal Project
-
批准号:10198495
-
项目类别:
-
资助金额:$52.56万
-
财政年份:2020
-
负责人:Ignacio E. Sanz
-
依托单位:
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity
-
批准号:10222320
-
项目类别:
-
资助金额:$79.55万
-
财政年份:2020
-
负责人:Ignacio E. Sanz
-
依托单位:
Project-002
-
批准号:10441807
-
项目类别:
-
资助金额:$56.09万
-
财政年份:2020
-
负责人:Ignacio E. Sanz
-
依托单位:
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity
-
批准号:10710093
-
项目类别:
-
资助金额:$54.51万
-
财政年份:2020
-
负责人:Ignacio E. Sanz
-
依托单位:
Molecular Regulation of B cells and T cells in Human SLE
-
批准号:10265746
-
项目类别:
-
资助金额:$56.09万
-
财政年份:2020
-
负责人:Ignacio E. Sanz
-
依托单位:
Plasma Cells in Health and Disease
-
批准号:10428164
-
项目类别:
-
资助金额:$269.59万
-
财政年份:2016
-
负责人:Ignacio E. Sanz
-
依托单位:
Project 1
-
批准号:10428167
-
项目类别:
-
资助金额:$55.02万
-
财政年份:2016
-
负责人:Ignacio E. Sanz
-
依托单位:
Project 4
-
批准号:10428170
-
项目类别:
-
资助金额:$54.2万
-
财政年份:2016
-
负责人:Ignacio E. Sanz
-
依托单位:
Administrative Core
-
批准号:10428165
-
项目类别:
-
资助金额:$10.18万
-
财政年份:2016
-
负责人:Ignacio E. Sanz
-
依托单位:
Administrative Core
-
批准号:10621322
-
项目类别:
-
资助金额:$10.18万
-
财政年份:2016
-
负责人:Ignacio E. Sanz
-
依托单位:
海外基金